REQUEST A DEMO
Total
USD $0.00
Search more companies

Med & Sul S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Med & Sul S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Med & Sul S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on March 26, 2018. It currently has a total number of 6 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 226.43% in 2023. There was a total growth of 54.33% in Med & Sul S.A.’s total assets over the same period. The net profit margin of Med & Sul S.A. increased by 1.5% in 2023.

Headquarters
Balsamos Sur 116 B
Guayaquil; Guayas;

Contact Details: Purchase the Med & Sul S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Med & Sul S.A. report to view the information.
Outstanding Shares:
Purchase the Med & Sul S.A. report to view the information.
Registered Capital:
Purchase the Med & Sul S.A. report to view the information.
Incorporation Date:
March 26, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Subsidiaries
Resto & Bar Mal de Amores Bar & amor S.A.
40%
Ovoletec S.A.
30%
Company Performance
Financial values in the chart are available after Med & Sul S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
226.43%
Total operating revenue
226.43%
Net Profit (Loss) for the Period
317.47%
Total assets
54.33%
Total equity
21.3%
Net Profit Margin
1.5%
Return on Equity (ROE)
5.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?